MALAT1 promotes the colorectal cancer malignancy by increasing DCP1A expression and miR203 downregulation

Mol Carcinog. 2018 Oct;57(10):1421-1431. doi: 10.1002/mc.22868. Epub 2018 Jul 12.

Abstract

The long non-coding RNA MALAT1 has been proved to promote the cell proliferation, drug resistance, invasion, and metastasis of colorectal cancer (CRC) in vitro and in vivo by regulating the expression of various oncogenes and their protein products. Our previous work discovered that the expression of the mRNA-decapping enzymes 1a (DCP1A) is upregulated in CRCs. However, the relationships between MALAT1 and DCP1A in the development of CRC and the underlying mechanisms are still unclear. In this study, we investigated the molecular mechanisms by which MALAT1 and DCP1A may be linked to contribute to the malignancies of CRCs. We found that DCP1A is a direct target molecule of MALAT1. Moreover, by screening the downstream genes of MALAT1, we noticed that microRNA 203(miR203), an oncogene suppressor in numerous cancers, is inversely correlated to both MALAT1 and DCP1A expressions. Following MALAT1 knockdown, we observed overexpression of miR203 accompanied with DCP1A downregulation to a level that reversed the promoted cell proliferation, invasion, and migration in vitro and in vivo, which could be restored by miR203 knockdown or DCP1A overexpression. These results proposed a new molecular mechanism of MALAT-miR203-DCP1A axis which is involved with the development and contributes to the malignancy of colorectal cancers.

Keywords: DCP1A; MALAT-1; colorectal cancer; long non-coding RNA; miR203.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Cell Movement / genetics
  • Cell Proliferation / genetics
  • Colorectal Neoplasms / genetics*
  • Colorectal Neoplasms / metabolism
  • Colorectal Neoplasms / therapy
  • Down-Regulation
  • Endoribonucleases / genetics*
  • Endoribonucleases / metabolism
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Mice
  • MicroRNAs / genetics*
  • RNA Interference
  • RNA, Long Noncoding / genetics*
  • RNAi Therapeutics / methods
  • Trans-Activators / genetics*
  • Trans-Activators / metabolism
  • Up-Regulation
  • Xenograft Model Antitumor Assays / methods

Substances

  • MALAT1 long non-coding RNA, human
  • MIRN203 microRNA, human
  • MicroRNAs
  • RNA, Long Noncoding
  • Trans-Activators
  • Endoribonucleases
  • DCP1A protein, human